A Pharmacokinetics‐Informed Approach to Navigating Hydroxychloroquine Shortages in Patients With Rheumatic Disease During the COVID‐19 Pandemic

OBJECTIVE: The recent hydroxychloroquine (HCQ) shortage due to use in coronavirus disease 2019 (COVID‐19) has forced some rheumatic disease patients to choose between continuing their current dose of HCQ but exhaust their supply early or ration it in order to prolong its use. Blood HCQ concentration...

Descripción completa

Detalles Bibliográficos
Autores principales: Scheetz, Marc H., Konig, Maximilian F., Robinson, Philip C., Sparks, Jeffrey A., Kim, Alfred H.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437131/
https://www.ncbi.nlm.nih.gov/pubmed/32725866
http://dx.doi.org/10.1002/acr2.11164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437131/
https://www.ncbi.nlm.nih.gov/pubmed/32725866
http://dx.doi.org/10.1002/acr2.11164

Ejemplares similares